Bilibili Inc vs Centene Corp — how do they compare? Bilibili Inc trades at $17.76 (market cap $7.71B), while Centene Corp trades at $66.33 (market cap $32.89B). The key difference: Centene Corp is far larger — about 4.3× Bilibili Inc's market cap, and Centene Corp is trading nearer its 52-week high, Bilibili Inc nearer its low. Which is the better fit depends on your goals.
| BILI | CNC | |
|---|---|---|
Market Cap | $7.71B | $32.89B |
Sector | Media | Health |
52-Week High | $35.92 | $68.72 |
52-Week Low | $15.96 | $26.17 |
Enterprise Value | $5.54B | $21.93B |
Signals from Pluang's Aura AI — not financial advice
Bilibili (BILI) trades at $18.74, up 0.48% with neutral technical signals. The company reported strong Q1 2026 earnings of $0.19 per share, beating estimates, and maintains solid profitability with a 4.58% net margin. Recent news highlights a new $300 million share repurchase program and upcoming Q2 2026 results on August 27, 2026. Technical indicators show mixed signals with RSI neutral but moving averages bullish.
Bilibili presents a compelling investment case with consistent earnings beats and strong analyst support (83% buy ratings). However, risks include competitive pressures in China's video platform market and reliance on advertising revenue growth. The upcoming Q2 earnings report will be crucial for validating the company's monetization strategy and user engagement metrics.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Bilibili is a leading video sharing and online entertainment platform for Gen Z in China. It offers a diverse range of content, including anime, games, and live broadcasting, fueled by a highly engaged community.
Read more on BILI →Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →